EKF Diagnostics Holdings Plc (EKF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EKF Diagnostics Holdings Plc (EKF) has a cash flow conversion efficiency ratio of 0.068x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX4.79 Million ≈ $582.44 USD) by net assets (GBX70.28 Million ≈ $8.55K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EKF Diagnostics Holdings Plc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
EKF Diagnostics Holdings Plc - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how EKF Diagnostics Holdings Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
EKF Diagnostics Holdings Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EKF Diagnostics Holdings Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Niraj Ispat Industries Limited
NSE:NIRAJISPAT
|
0.006x |
|
Fuse Cobalt Inc
V:FUSE
|
-0.057x |
|
Luminar Technologies Inc. Class A
NASDAQ:LAZRQ
|
0.106x |
|
Smartfren Telecom Tbk
JK:FREN
|
-0.016x |
|
GCP Asset Backed Income Fund Limited
LSE:GABI
|
0.107x |
|
Aptitude Software Group PLC
LSE:APTD
|
-0.016x |
|
GlucoTrack Inc
NASDAQ:GCTK
|
-1.392x |
|
Polledo S.A.
BA:POLL
|
0.130x |
Annual Cash Flow Conversion Efficiency for EKF Diagnostics Holdings Plc (2001–2025)
The table below shows the annual cash flow conversion efficiency of EKF Diagnostics Holdings Plc from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see EKF stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX70.28 Million ≈ $8.55K |
GBX9.71 Million ≈ $1.18K |
0.138x | -25.95% |
| 2024-12-31 | GBX73.21 Million ≈ $8.91K |
GBX13.66 Million ≈ $1.66K |
0.187x | +101.62% |
| 2023-12-31 | GBX68.22 Million ≈ $8.30K |
GBX6.31 Million ≈ $767.87 |
0.093x | -28.84% |
| 2022-12-31 | GBX74.52 Million ≈ $9.07K |
GBX9.69 Million ≈ $1.18K |
0.130x | +20.30% |
| 2021-12-31 | GBX94.74 Million ≈ $11.53K |
GBX10.24 Million ≈ $1.25K |
0.108x | -38.80% |
| 2020-12-31 | GBX78.20 Million ≈ $9.51K |
GBX13.81 Million ≈ $1.68K |
0.177x | +146.43% |
| 2019-12-31 | GBX71.17 Million ≈ $8.66K |
GBX5.10 Million ≈ $620.52 |
0.072x | -44.98% |
| 2018-12-31 | GBX63.90 Million ≈ $7.78K |
GBX8.32 Million ≈ $1.01K |
0.130x | -12.96% |
| 2017-12-31 | GBX60.50 Million ≈ $7.36K |
GBX9.05 Million ≈ $1.10K |
0.150x | +2.02% |
| 2016-12-31 | GBX60.97 Million ≈ $7.42K |
GBX8.94 Million ≈ $1.09K |
0.147x | +260.04% |
| 2015-12-31 | GBX46.75 Million ≈ $5.69K |
GBX-4.29 Million ≈ $-521.36 |
-0.092x | -68.80% |
| 2014-12-31 | GBX87.38 Million ≈ $10.63K |
GBX-4.74 Million ≈ $-577.21 |
-0.054x | -210.70% |
| 2013-12-31 | GBX40.92 Million ≈ $4.98K |
GBX2.01 Million ≈ $244.19 |
0.049x | +20.93% |
| 2012-12-31 | GBX39.43 Million ≈ $4.80K |
GBX1.60 Million ≈ $194.55 |
0.041x | +288.32% |
| 2011-12-31 | GBX37.43 Million ≈ $4.55K |
GBX-806.00K ≈ $-98.07 |
-0.022x | +64.04% |
| 2010-12-31 | GBX23.53 Million ≈ $2.86K |
GBX-1.41 Million ≈ $-171.43 |
-0.060x | +50.22% |
| 2009-12-31 | GBX5.62 Million ≈ $683.79 |
GBX-676.00K ≈ $-82.25 |
-0.120x | +5.74% |
| 2008-12-31 | GBX5.07 Million ≈ $616.87 |
GBX-647.00K ≈ $-78.72 |
-0.128x | -210.05% |
| 2007-12-31 | GBX4.98 Million ≈ $605.44 |
GBX577.00K ≈ $70.20 |
0.116x | +160.35% |
| 2006-12-31 | GBX4.30 Million ≈ $523.06 |
GBX-826.00K ≈ $-100.50 |
-0.192x | -3668.00% |
| 2005-12-31 | GBX3.71 Million ≈ $451.89 |
GBX20.00K ≈ $2.43 |
0.005x | +101.97% |
| 2004-12-31 | GBX3.12 Million ≈ $379.01 |
GBX-852.00K ≈ $-103.66 |
-0.274x | -2390.00% |
| 2003-12-31 | GBX2.46 Million ≈ $299.07 |
GBX-27.00K ≈ $-3.29 |
-0.011x | -498.46% |
| 2002-12-31 | GBX2.90 Million ≈ $353.09 |
GBX8.00K ≈ $0.97 |
0.003x | -99.58% |
| 2001-12-31 | GBX214.00K ≈ $26.04 |
GBX142.00K ≈ $17.28 |
0.664x | -- |
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm analyzer; Hemo Control, a hemoglobin analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit rea… Read more